Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
The company is confident of addressing all the observations within the stipulated time
Investment is additive to KKR’s existing health care growth strategy
The vaccine further advances Pfizer’s vaccine portfolio and builds on more than 20 years of expertise and knowledge in the prevention of meningococcal disease
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials
hey were educated about the 7- step hand-washing technique trainings
Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Subscribe To Our Newsletter & Stay Updated
